CLINICAL_TRIALS
trial_result
· 2009-12-17
Clinical Trial Update: Impact of Fibroblast Growth Factor 23 (FGF-23) and Serum Phosphate on Allograft Function and Mortality in Kidney Allograft Recipients
Summary
The trial explores whether FGF-23 and serum phosphate levels affect allograft function and mortality in kidney transplant recipients; the snippet provides no re…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ramathibodi Hospital | Conditions: Kidney Transplantation | Status: UNKNOWN